Pfizer Aktie
WKN: 852009 / ISIN: US7170811035
|
27.12.2024 17:11:26
|
BioNTech Enters Into Settlements With U.S. Agency, UPenn Over COVID-19 Vaccine Royalties
(RTTNews) - BioNTech SE (BNTX), Friday reached two separate settlements with the U.S. National Institutes of Health, and the University of Pennsylvania regarding the royalties payment of COVID-19 vaccine.
The Germany-based company has agreed to pay $791.5 million to the U.S. agency, whereas it would pay $467 million to UPenn to dismiss the lawsuit.
Moreover, BioNTech's partner Pfizer (PFE) for its COVID-19 vaccine has agreed to reimburse the company for up to $170 million of the claimed royalties payable to Penn for 2020-2023 sales in connection with the proposed Settlement Agreement.
Concurrently, the company has amended its license agreements to provide for a low single-digit percentage royalty on Net Sales of Licensed Products for 2024 onwards.
Currently, BioNTech's stock is trading at $114.25, up 0.42 percent on the Nasdaq.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu BioNTech (ADRs)mehr Nachrichten
Analysen zu BioNTech (ADRs)mehr Analysen
| 03.12.25 | BioNTech Buy | Jefferies & Company Inc. | |
| 25.11.25 | BioNTech Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.11.25 | BioNTech Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.11.25 | BioNTech Buy | Jefferies & Company Inc. | |
| 07.11.25 | BioNTech Neutral | UBS AG |
Aktien in diesem Artikel
| BioNTech (ADRs) | 82,50 | 0,00% |
|
| Pfizer Inc. | 22,25 | -0,54% |
|
Letzte Top-Ranking Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.